Zoledronic Acid Injection, Solution
Product Images NDC 68083-135

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 68083-135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zoledronic-spl-carton (Zoledronic Spl Carton)

Zoledronic-spl-carton (Zoledronic Spl Carton)
This text contains information about a medication called "Zoledronic Acid Injection" which is administered through intravenous infusion. It comes in a single-dose vial of 100 mL with a concentration of 5 mg per 100 mL. There are also references to a medication guide which is provided to each patient.*
FDA Label Image

Zoledronic-spl-container (Zoledronic Spl Container)

FDA Label Image

Zoledronic-spl-structure (Zoledronic Spl Structure)

FDA Label Image

Zoledronic-spl-graph1 (Zoledronic Spl Graph1)

FDA Label Image

Zoledronic-spl-graph2 (Zoledronic Spl Graph2)

Zoledronic-spl-graph2 (Zoledronic Spl Graph2)
Therapeutic response over time is being evaluated, specifically the normalization of serum alkaline phosphatase (SAF) levels over a period of time.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.